We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+10.01%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$3.38B
AUM Growth
–
Cap. Flow
+$3.36B
Cap. Flow %
99.4%
Top 10 Hldgs %
42.06%
Holding
56
New
56
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$186M
2
INCY icon
Incyte
INCY
+$167M
3
GILD icon
Gilead Sciences
GILD
+$153M
4
VTRS icon
Viatris
VTRS
+$141M
5
MDVN
MEDIVATION, INC.
MDVN
+$137M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 83.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOLX
26
DELISTED
Hologic
HOLX
$51.3M 1.52%
+2,656,554
New +$55.5M
NXTM
27
DELISTED
NxStage Medical Inc.
NXTM
$50.8M 1.5%
+3,555,725
New +$44.7M
IRWD icon
28
Ironwood Pharmaceuticals
IRWD
$611M
$50.5M 1.49%
+6,077,516
New +$73.7M
ALXN
29
DELISTED
Alexion Pharmaceuticals
ALXN
$47.2M 1.4%
+512,108
New +$49.4M
SHPG
30
DELISTED
Shire pic
SHPG
$46.8M 1.38%
+492,333
New +$46.2M
TMO icon
31
Thermo Fisher Scientific
TMO
$211B
$43M 1.27%
+507,800
New +$42.3M
PCYC
32
DELISTED
PHARMACYCLICS INC
PCYC
$38.7M 1.15%
+487,224
New +$39.8M
DXCM icon
33
DexCom
DXCM
$27.6B
$36.4M 1.08%
+6,492,196
New +$31.1M
NPSP
34
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$34.8M 1.03%
+2,302,428
New +$31.9M
COV
35
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$29.7M 0.88%
+533,016
New +$30.8M
PTLA
36
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$27.9M 0.82%
+1,134,038
New +$22.5M
HALO icon
37
Halozyme
HALO
$9.72B
$25.9M 0.77%
+3,260,962
New +$20.8M
UTHR icon
38
United Therapeutics
UTHR
$26.3B
$21.1M 0.62%
+321,032
New +$20.7M
SQNM
39
DELISTED
SEQUENOM INC NEW
SQNM
$17.3M 0.51%
+4,103,868
New +$16.4M
RDY icon
40
Dr. Reddy's Laboratories
RDY
$9.82B
$16.6M 0.49%
+2,192,200
New +$16M
VPHM
41
DELISTED
VIROPHARMA INC
VPHM
$16M 0.47%
+559,724
New +$14.8M
TEVA icon
42
Teva Pharmaceuticals
TEVA
$35.9B
$16M 0.47%
+407,749
New +$15.9M
THOR
43
DELISTED
THORATEC CORPORATION
THOR
$14.7M 0.44%
+470,118
New +$15.8M
CLVS
44
DELISTED
Clovis Oncology, Inc.
CLVS
$14.2M 0.42%
+212,700
New +$9.56M
SGEN
45
DELISTED
Seagen Inc. Common Stock
SGEN
$13.3M 0.39%
+421,769
New +$14.7M
SGNT
46
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$12.8M 0.38%
+610,056
New +$10.9M
MNTA
47
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$12.7M 0.38%
+846,196
New +$11.2M
ACHN
48
DELISTED
Achillion Pharmaceuticals
ACHN
$12.4M 0.37%
+1,514,700
New +$11.6M
FRX
49
DELISTED
FOREST LABORATORIES INC
FRX
$11.6M 0.34%
+283,075
New +$10.9M
AKRX
50
DELISTED
Akorn Inc
AKRX
$10.7M 0.32%
+792,782
New +$11.2M
1
2
3

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Sectoral Asset Management, which disclosed 56 positions worth $3.38B. Its ten largest holdings account for 42% of the portfolio.

Its largest position is Vertex Pharmaceuticals: 2,526,014 shares worth $202M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets.

  • Sectoral Asset Management's largest Q2 2013 buy was Vertex Pharmaceuticals: 2,526,014 shares worth $202M.
  • Sectoral Asset Management's ten largest holdings make up 42% of its $3.38B portfolio in Q2 2013.
  • Sectoral Asset Management disclosed 56 positions in Q2 2013, its first 13F filing on record.

Based on Sectoral Asset Management's 13F filing for Q2 2013, filed 12 Aug 2013.